Becton Dickinson and
235.82
-0.37 (-0.16%)
At close: Jan 14, 2025, 3:59 PM
235.80
-0.01%
After-hours Jan 14, 2025, 07:00 PM EST
undefined%
Bid 233.41
Market Cap 68.39B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 5.86
PE Ratio (ttm) 40.24
Forward PE n/a
Analyst Buy
Ask 239.16
Volume 1,822,449
Avg. Volume (20D) 1,816,927
Open 236.50
Previous Close 236.19
Day's Range 233.01 - 237.40
52-Week Range 218.75 - 248.42
Beta undefined

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...

Sector Healthcare
IPO Date Feb 21, 1973
Employees 70,000
Stock Exchange NYSE
Ticker Symbol BDX

Analyst Forecast

According to 6 analyst ratings, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $275, which is an increase of 16.61% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Becton Dickinson and is scheduled to release its earnings on Feb 6, 2025, before market opens.
Analysts project revenue of $5.12B, reflecting a 8.80% YoY growth and earnings per share of 2.99, making a 11.57% increase YoY.
2 months ago · Source
-5.39%
BD shares are trading lower following Q4 earnings.... Unlock content with Pro Subscription
2 months ago · Source
-5.39%
Becton, Dickinson and Company shares are trading lower. The company reported Q4 financial results.